Clinical Trials

Inclusion Criteria:

• Males and females who are 18 years of age or older.
• Have radiographically or pathologically confirmed diagnosis of NASH or a newly diagnosed fatty liver or identified to have elevated liver enzymes.
• Does not have a diagnosis of HIV or AIDS.
• Do not have a diagnosis of other etiologies of liver cancer (e.g., viral hepatitis B or C, alcoholic liver disease, alcohol abuse, or rare genetic syndromes that predisposes to liver cancer).
• Are compos mentis: of sound mind, memory and understanding, and able to provide written informed consent.

Exclusion Criteria:

• Is under the age of 18 years or over the age of 100 years.
• Is not mentally competent to provide consent.
• Has been diagnosed with post-traumatic stress disorder(PTSD).
• Has a diagnosis of HIV or AIDS.
• Is institutionalized (e.g., FMC patients or nursing home).
• Has a diagnosis of any of the following conditions:
  • History of hepatitis B or C virus (HBV, HCV) infections;
  • History of alcoholic liver disease or alcohol abuse;
  • Autoimmune hepatitis;
  • Alpha-1-antitrypsin deficiency;
  • Hemochromatosis;
  • Wilson’s disease;
  • Biliary cirrhosis;
  • Consume ≥ 20 grams of alcohol/day or > 1 drink/day for women and > 2 drinks/day.
  • Stage 4 fibrosis (i.e. cirrhosis)
  • Any cancer

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/19/24. Questions regarding updates should be directed to the study team contact.